Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
3.860
+0.050 (1.31%)
At close: Sep 26, 2025, 4:00 PM EDT
3.900
+0.040 (1.04%)
After-hours: Sep 26, 2025, 7:31 PM EDT
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $15.22 million as of September 26, 2025. Its market cap has decreased by -19.18% in one year.
Market Cap
15.22M
Enterprise Value
-13.58M
1-Year Change
-19.18%
Ranking
Category
Stock Price
$3.86
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $15.22M, a decrease of -96.89%. That is a compound annual growth rate of -49.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 15.22M | -32.90% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |